Street bets on Cipla's respiratory drug portfolio to drive growth

Retrieved on: 2021-07-09 06:11:15

Tags for this article:

Click the tags to see associated articles and topics

Street bets on Cipla's respiratory drug portfolio to drive growth. View article details on hiswai:

Excerpt

Covid treatments drugs, including remdesivir, have kept the company's India sales growth strong. The company's June quarter sales have grown ...

Article found on: www.livemint.com